FRIDAY, April 9, 2021 (HealthDay News) – Being active is good for most everyone, and new studies now show it can help kids with autism manage common behavioral issues. “Exercise goes beyond health-related benefits and increased levels of fitness for those with autism,” said David Geslak, a pioneer in usingContinue Reading
THURSDAY, April 8, 2021 (HealthDay News) — A new clinical trial will investigate whether people who are highly allergic or have what’s known as a mast cell disorder are at higher risk for a sudden allergic reaction to the Moderna or Pfizer COVID-19 vaccines. “The public understandably has been concernedContinue Reading
THURSDAY, April 8, 2021 (HealthDay News) — Two COVID-19 vaccines appear to work well against a rapidly spreading coronavirus variant that arose in California, but less effective against a variant that first emerged in South Africa, researchers report. “The good news is the California variant does not appear to beContinue Reading
THURSDAY, April 8, 2021 (HealthDay News) — COVID-19 death rates are significantly higher among Black American women than among white men, according to a new study, suggesting that race is a factor in survival differences between men and women. Researchers analyzed COVID death rates in Michigan and Georgia, the onlyContinue Reading
THURSDAY, April 8, 2021 (HealthDay News) — Could banning menthol cigarettes be key to lowering smoking rates overall? New research suggests it’s possible, after finding that a ban on menthol cigarettes in Canada was linked to a large increase in the number of smokers who quit. The impact of theContinue Reading
THURSDAY, April 8, 2021 (HealthDay News) — In a discovery that shows carpal tunnel syndrome doesn’t strike just office workers, researchers report that people who work in construction or manufacturing have a higher risk of carpal tunnel syndrome than those with desk jobs. Why the higher rates of injury amongContinue Reading
WEDNESDAY, April 7, 2021 (HealthDay News) — Two people in the Johnson & Johnson COVID-19 vaccine trial developed Guillain-Barré syndrome, but it’s highly doubtful the vaccine is to blame, according to a just-published case study. Although both people were in the same trial, one was given the vaccine and theContinue Reading
WEDNESDAY, April 7, 2021 (HealthDay News) — Being jailed puts teens with untreated psychiatric disorders at increased risk for long-term mental health struggles, researchers say. “These are not necessarily bad kids, but they have many strikes against them,” said study lead author Linda Teplin. “Physical abuse, sexual abuse and neglectContinue Reading
WEDNESDAY, April 7, 2021 (HealthDay News) — In findings that bode well for the full reopening of schools across America, a new government survey shows that nearly 80 percent of school employees and child care workers have received at least one dose of a coronavirus vaccine. Released by the U.S.Continue Reading
WEDNESDAY, April 7, 2021 (HealthDay News) — COVID-19 is so contagious that even a single breach of social distancing measures can have far-reaching consequences. A case in point: An explosion of new COVID-19 cases traced to five people who joined in on a bar’s opening night in rural Illinois inContinue Reading
WEDNESDAY, April 7, 2021 (HealthDay News) — Americans’ trust in the Centers for Disease Control and Prevention (CDC) has declined during the COVID-19 pandemic, an opinion poll finds. Researchers polled more than 2,000 Americans in May 2020 and questioned most again five months later. Respondents were asked to rate theirContinue Reading
TUESDAY, April 6, 2021 (HealthDay News) — U.S. children commonly wait hours in the emergency room for help with a mental health crisis — a problem that has worsened over time, a new study finds. Researchers found that between 2005 and 2015, prolonged ER stays became ever more common forContinue Reading
TUESDAY, April 6, 2021 (HealthDay News) — There’s good news for the millions of Americans who’ve already received a dose or two of Moderna’s COVID-19 vaccine: New research shows the vaccine should protect against illness for at least six months. The new study tracked 33 participants in the trials thatContinue Reading
TUESDAY, April 6, 2021 (HealthDay News) — The first new drug developed in over a decade for children with attention deficit hyperactivity disorder (ADHD) has been approved by the U.S. Food and Drug Administration. Qelbree, also known as viloxazine, comes in a capsule that is taken daily, and is notContinue Reading